TLCR Reading Tools
How to cite item
Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study)
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{31057}, author = {Iwasaku, M., Uchino, J., Yamada, T., Chihara, Y., Shimamoto, T., Tamiya, N., Kaneko, Y., Kiyomi, F., Takayama, K.}, title = {Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study)}, journal = {Translational Lung Cancer Research}, volume = {8}, number = {4}, year = {2019}, url = {https://tlcr.amegroups.org/article/view/31057} }